Hydroxyurea showed more dose-limiting toxicities than placebo but reduced clinical AEs and improved hematological parameters, ...

The holiday season increases cardiac risks and reduces medical access, making proactive cardiac health strategies essential ...

In the phase 3 LUNA 3 trial, rilzabrutinib, compared with placebo, improved efficacy and QOL outcomes with an accompanying ...

Revumenib displayed promising anti-tumor activity among patients with relapsed or refractory KMT2Ar acute leukemia.

The following is a summary of “A nationwide study of two decades of invasive pneumococcal disease in the Faroe Islands, ...

The following is a summary of “Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and ...

The following is a summary of “Role of Language in Hospital Admissions: The COVID-19 Experience in a Safety-Net Hospital ...

The following is a summary of “Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary ...

The following is a summary of “Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis,” ...

The following is a summary of “Characterization of peripapillary hyperreflective ovoid mass-like structures (PHOMS) in a ...

The following is a summary of “Multiomic molecular patterns of lipid dysregulation in a subphenotype of sepsis with higher ...

Fast subjective walking speed is associated with lower odds of metabolic diseases among individuals with obesity, according ...